Dishman Pharmaceuticals and Chemicals and three Saudi Arabian partners, have established a joint venture to manufacture APIs in Saudi Arabia. Dishman has invested $9m for a 30% stake in CAD. The Arab Company for Drug Industries and Medical Appliances (ACDIMA) has a 15% stake, Spimaco 20% and Capital Advisory Group 25%. The facility is due on line towards the end of 2010.
Dishman is also investing $32m in four contract manufacturing plants at its SEZ and another $32m in expanding its Bavla facility.
Business Standard
Sunday 13 December 2009
Dishman invests in Saudi Arabia and India
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment